New and deleted products
Patients with paroxysmal atrial fibrillation (AF) are...
Zalviso (sufentanil) is licensed to treat with acute...
Varuby (rolapitant) is a new NK1 antagonist...
Trumenba is now one of two meningitis B vaccines available...
Patients with diabetes who use the NovoPen Echo or...
Featured MIMS resources
Instructions for changing or stopping antidepressants.
Summary of NICE guidance on Helicobacter treatment.
Hormone doses and costs of HRT preparations.
Strengths and formulations of topical steroids.
Dose regimens for common bacterial infections.
Partner CPD from MIMS Learning
Initiated, funded and reviewed by Reckitt Benckiser. Date of Preparation: February 2017; UK/E45-NHS/0916/0013j
Lessons from the Ealing GP Federation Funding for this educational programme has been provided by Bayer, Boehringer Ingelheim and Daiichi Sankyo. None of the companies have had any influence or input into its content.
Initiated, funded and reviewed by Teva Respiratory. Teva UK Limited, Field House, Station Approach, Harlow, Essex, CM20 2FB
New products coming soon to MIMS
Check back soon to find MIMS listings for the following new drugs:
Fertavid (follitropin beta)
Infanrix hexa (DTaP/IPV/Hib/HBV vaccine)
Panzyga (human normal immunoglobulin)
Suliqua (insulin glargine/lixisenatide)
Vemlidy (tenofovir alafenamide fumarate)
Register or Subscribe to MIMSGPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.
MIMS bulletinsNews and updates straight to your inbox.
Prescribing Update: Fortnightly news bulletin
Alert: Urgent prescribing updates
Spotlight: Disease-themed monthly round-up
Read the latest issue online exclusively on MIMS Learning.
Especially created for prescribing influencers.